Rhenman & Partners Asset Management AB Buys Shares of 51,000 Stevanato Group S.p.A. $STVN

Rhenman & Partners Asset Management AB purchased a new position in Stevanato Group S.p.A. (NYSE:STVN) during the third quarter, Holdings Channel.com reports. The institutional investor purchased 51,000 shares of the company’s stock, valued at approximately $1,313,000.

Several other large investors have also recently made changes to their positions in STVN. Farther Finance Advisors LLC acquired a new position in Stevanato Group in the 3rd quarter valued at $44,000. First Horizon Corp acquired a new stake in Stevanato Group during the 3rd quarter worth $50,000. State of Wyoming boosted its stake in Stevanato Group by 39,216.7% during the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after purchasing an additional 2,353 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Stevanato Group during the third quarter worth $68,000. Finally, Van Berkom & Associates Inc. grew its holdings in shares of Stevanato Group by 50.6% during the third quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after buying an additional 1,215 shares in the last quarter.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on STVN shares. Weiss Ratings reissued a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. KeyCorp cut their price objective on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday. Citigroup lowered their target price on Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a report on Thursday. Morgan Stanley cut their price target on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday. Finally, Jefferies Financial Group set a $17.50 price objective on Stevanato Group in a research note on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

Stevanato Group Stock Down 2.8%

NYSE:STVN opened at €15.46 on Friday. Stevanato Group S.p.A. has a 52 week low of €13.91 and a 52 week high of €28.00. The stock’s fifty day moving average is €17.58 and its two-hundred day moving average is €21.65. The stock has a market capitalization of $4.68 billion, a price-to-earnings ratio of 26.66, a price-to-earnings-growth ratio of 1.42 and a beta of 0.57. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.23.

Stevanato Group News Summary

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Q4 beats and revenue momentum — Stevanato reported Q4 results that beat expectations (reported EPS ~$0.2114 vs. ~$0.20 consensus) and highlighted strong revenue growth, reinforcing demand for its pharmaceutical packaging and high‑value solutions. STVN Q4 Highlights
• Positive Sentiment: 2026 guidance and HVS mix — Management outlined a 2026 revenue target up to €1.308B and expects high‑value solutions (HVS) to reach ~48% of sales, supporting margin expansion potential as capex is mainly HVS‑directed. 2026 Revenue Target Article
• Positive Sentiment: Analyst buy support — At least one note (Seeking Alpha piece) reiterates a Buy thesis citing Q4/FY25 strength and long‑term demand drivers, framing current weakness as cyclical in the Engineering segment. Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story
• Neutral Sentiment: Earnings call detail — Full Q4/FY25 earnings call transcripts and summaries are available for deeper read; they provide management color on capex allocation (heavy toward HVS) and the cyclical pressure in Engineering. Useful for modeling near‑term margin recovery timing. Q4 2025 Earnings Call Summary
• Neutral Sentiment: Transcripts published — Full call transcripts (Seeking Alpha / InsiderMonkey) confirm the beat and provide verbatim management commentary for investors building scenarios. Earnings Call Transcript
• Negative Sentiment: Multiple analyst price‑target cuts — Morgan Stanley cut its PT to $19 and moved to Equal Weight; Citigroup lowered its PT to $26 (maintained Buy); KeyCorp trimmed its PT to $32 (keeps Overweight). Those revisions reduce near‑term upside expectations and likely contributed to selling pressure. Analyst PT Changes (Benzinga) KeyBanc / StreetInsider

Stevanato Group Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.